News
NeoChord Announces $25 Million Series D Financing to Accelerate Development of Two Transcatheter Chordal Repair Programs
November 2018
CLICK FOR RELEASE
NeoChord Announces Successful Completion of First Beating Heart Repair Procedures in China
September 2018
CLICK FOR RELEASE
Neochord DS1000 System Successfully Treats 20th Patient in Combination with Other Beating Heart Procedures
April 2018
CLICK FOR RELEASE
NeoChord Announces a Research Collaboration with the Skirball Center for Innovation at the Cardiovascular Research Foundation
January 2018
CLICK FOR RELEASE
Andrew ElBardissi, M.D. Named to NeoChord Board of Directors
June 2017
CLICK FORÂ RELEASE
NeoChord Names J. Alex Martin Chairman of the Board
January 2017
CLICK FOR RELEASE
First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation;
November 2016
click for release
NeoChord passes 500 patient treatment milestone follow-up data on 127 patients out to two years presented at EACTS;
October 2016
click for release
NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation;
May 2016
Click for Release
NeoChord announces appointment of Alex Jonkers as VP of European Commercial Sales and milestone of over 400 patients treated with the DS1000 System;
May 2016
Click for Release
